[HTML][HTML] CE–MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer
M Frantzi, E Gomez Gomez… - British journal of …, 2019 - nature.com
Background Prostate cancer progresses slowly when present in low risk forms but can be
lethal when it progresses to metastatic disease. A non-invasive test that can detect …
lethal when it progresses to metastatic disease. A non-invasive test that can detect …
[HTML][HTML] CE–MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer
M Frantzi, EG Gomez, AB Pedregosa… - British Journal of …, 2019 - ncbi.nlm.nih.gov
Background Prostate cancer progresses slowly when present in low risk forms but can be
lethal when it progresses to metastatic disease. A non-invasive test that can detect …
lethal when it progresses to metastatic disease. A non-invasive test that can detect …
CE–MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer
M Frantzi, EG Gomez, AB Pedregosa… - British Journal of …, 2019 - research.uni-luebeck.de
Background: Prostate cancer progresses slowly when present in low risk forms but can be
lethal when it progresses to metastatic disease. A non-invasive test that can detect …
lethal when it progresses to metastatic disease. A non-invasive test that can detect …
CE-MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer.
M Frantzi, B Pedregosa, A Latosinska… - British Journal of …, 2019 - europepmc.org
Background Prostate cancer progresses slowly when present in low risk forms but can be
lethal when it progresses to metastatic disease. A non-invasive test that can detect …
lethal when it progresses to metastatic disease. A non-invasive test that can detect …
CE-MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer
M Frantzi, EG Gomez, AB Pedregosa… - British journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Prostate cancer progresses slowly when present in low risk forms but can be
lethal when it progresses to metastatic disease. A non-invasive test that can detect …
lethal when it progresses to metastatic disease. A non-invasive test that can detect …
CE–MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer
M Frantzi, EG Gomez, AB Pedregosa… - British Journal of …, 2019 - research.uni-luebeck.de
Background: Prostate cancer progresses slowly when present in low risk forms but can be
lethal when it progresses to metastatic disease. A non-invasive test that can detect …
lethal when it progresses to metastatic disease. A non-invasive test that can detect …